Arbutus Biopharma Corporation (ABUS)

New Form 8-K - Arbutus Biopharma Corp Filed: 2025-06-25 AccNo: 0001171843-25-004094 Size: 270 KB Item 1.02: Termination of a Material Definitive Agreement Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

Kymera Therapeutics Inc (KYMR)

New Form 8-K - Kymera Therapeutics, Inc. Filed: 2025-06-25 AccNo: 0001193125-25-146135 Size: 171 KB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

Kymera Therapeutics Inc (KYMR)

New Form 8-K - Kymera Therapeutics, Inc. Filed: 2025-06-25 AccNo: 0001193125-25-146134 Size: 203 KB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits